Fatty Acid Incubation of Myotubes From Humans With Type 2 Diabetes Leads to Enhanced Release of β-Oxidation Products Because of Impaired Fatty Acid Oxidation
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Increased availability of fatty acids is important for accumulation of intracellular lipids and development of insulin resistance in human myotubes. It is unknown whether different types of fatty acids like eicosapentaenoic acid (EPA) or tetradecylthioacetic acid (TTA) influence these processes. RESEARCH DESIGN AND METHODS: We examined fatty acid and glucose metabolism and gene expression in cultured human skeletal muscle cells from control and type 2 diabetic individuals after 4 days of preincubation with EPA or TTA. RESULTS: Type 2 diabetes myotubes exhibited reduced formation of CO(2) from palmitic acid (PA), whereas release of beta-oxidation products was unchanged at baseline but significantly increased with respect to control myotubes after preincubation with TTA and EPA. Preincubation with TTA enhanced both complete (CO2) and beta-oxidation of palmitic acid, whereas EPA increased only beta-oxidation significantly. EPA markedly enhanced triacylglycerol (TAG) accumulation in myotubes, more pronounced in type 2 diabetes cells. TAG accumulation and fatty acid oxidation were inversely correlated only after EPA preincubation, and total level of acyl-CoA was reduced. Glucose oxidation (CO2 formation) was enhanced and lactate production decreased after chronic exposure to EPA and TTA, whereas glucose uptake and storage were unchanged. EPA and especially TTA increased the expression of genes involved in fatty acid uptake, activation, accumulation, and oxidation. CONCLUSIONS: Our results suggest that 1) mitochondrial dysfunction in diabetic myotubes is caused by disturbances downstream of fatty acid beta-oxidation; 2) EPA promoted accumulation of TAG, enhanced beta-oxidation, and increased glucose oxidation; and 3) TTA improved complete palmitic acid oxidation in diabetic myotubes, opposed increased lipid accumulation, and increased glucose oxidation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![FIG. 1. Palmitate uptake and oxidation. Differentiated myotubes from type 2 diabetic or control subjects were preincubated with 40 μmol/l BSA, 100 μmol/l oleic acid, 100 μmol/l TTA, or 100 μmol/l EPA for 4 days and incubated with 0.6 mmol/l [1-14C]PA for 4 h. The panels show palmitate uptake, which is the sum of total recovered CO2, ASMs, and total lipids (A); oxidation to CO2 (B); CO2 from palmitic acid as percentage of total oxidation (C). Results present means ± SE (n = 8). a, P ≤ 0.05 vs. baseline; b, P ≤ 0.05 vs. oleic acid; c, P ≤ 0.05 vs. EPA; #P ≤ 0.05 vs. ObControl, analyzed by linear mixed models statistics (SPSS), which also calculated the allover results based on all available data. T2D, type 2 diabetes.](https://figures.cochat.ai/paper-figures/2c2dced4d81c4e6689a659972b457654/fatty-acid-incubation-of-myotubes-from-humans-with-type-2-diabetes-leads-to-figure-1.jpg)
![FIG. 2. Palmitate-derived ASMs release to the medium. Differentiated myotubes from type 2 diabetes or control subjects were preincubated with fatty acids as described in Fig. 1 and then acutely incubated with 0.6 mmol/l [1-14C]PA ± 1 μmol/l insulin for 4 h. The panels show ASMs released from the cells, derived from 14C–palmitic acid without (A) and with (B) 1 μmol/l insulin. Results represent means ± SE (n = 6–7). a, P ≤ 0.05 vs. baseline; b, P ≤ 0.05 vs. oleic acid; #P ≤ 0.05 vs. ObControl, analyzed by linear mixed models statistics (SPSS), which also calculated the allover results based on all available data.](https://figures.cochat.ai/paper-figures/02c6a20379f448eb808b88b20bf8680b/fatty-acid-incubation-of-myotubes-from-humans-with-type-2-diabetes-leads-to-figure-2.jpg)
![FIG. 3. Changes in TAG accumulation from 14C–palmitic acid relative to baseline (A) and negative correlation between changes in 14C–palmitic acid oxidation and TAG accumulation after preincubation with EPA (B). Differentiated myotubes from type 2 diabetic or control subjects were preincubated with fatty acids as described in Fig. 1 and then acutely incubated with [1-14C]PA (0.6 mmol/l) for 4 h. The panels show changes in 14C–palmitic acid–derived TAGs as percentage of baseline (BSA) (A) and a negative correlation between changes in total 14C–palmitic acid oxidation and TAG accumulation in myotubes preincubated with EPA (r = −0.69, P < 0.001). Results represent means ± SE (n = 8). a, P ≤ 0.05 vs. baseline; b, P ≤ 0.05 vs. oleic acid; c, P ≤ 0.05 vs. EPA; #P ≤ 0.05 vs. ObControl, analyzed by linear mixed models statistics (SPSS), which also calculated the allover results based on all available data.](https://figures.cochat.ai/paper-figures/a9a024e0b9a04383b905c1376be04668/fatty-acid-incubation-of-myotubes-from-humans-with-type-2-diabetes-leads-to-figure-3.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Wensaas and colleagues (2008) also observed a marked increase in TAG synthesis following EPA treatment in isolated skeletal muscle myotubes and this effect was more pronounced in myotubes isolated from T2D individuals [133].”
From Omega-3 Fatty Acids and Skeletal Muscle Health (2015) · cites this paper as [133]
In the citing paper
“EPA also reduced the amount of C:18-2 CoA beyond that of control and again this effect was more pronounced in T2D myotubes.”
From Omega-3 Fatty Acids and Skeletal Muscle Health (2015) · cites this paper as [133]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197 · cited 1×
“PGC1 is an important regulator of muscle oxidative capacity, mitochondrial content, and fiber type (31,32), and insulin resistance may be negatively associated with PGC1 expression in skeletal muscle (33,34).”
BackgroundWu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139
Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres
Lin, J., Wu, H., Tarr, P. T., Zhang, C.-Y., Wu, Z., Boss, O., Michael, L. F., Puigserver, P., Isotani, E., Olson, E. N., et al. (2002) · Nature · doi:10.1038/nature00904 · Cited by 2,546
Mitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107 · cited 1×
“In support for this, several studies have suggested a mitochondrial dysfunction in the etiology of insulin resistance and type 2 diabetes (4,6,28).”
BackgroundTriglyceride accumulation protects against fatty acid-induced lipotoxicity
Listenberger, L. L., Han, X., Lewis, S. E., Cases, S., Farese, R. V., Ory, D. S., & Schaffer, J. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630588100 · Cited by 2,075
Koves, T. R., Ussher, J. R., Noland, R. C., Slentz, D., Mosedale, M., Ilkayeva, O., Bain, J., Stevens, R., Dyck, J. R. B., Newgard, C. B., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.013 · Cited by 1,990
Patti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952
Yu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200958200 · Cited by 1,561 · cited 1×
“Increased levels of acyl-CoA and especially C18:2-CoA have been associated with insulin resistance (42,43).”
BackgroundSkeletal Muscle Triglyceride Levels Are Inversely Related to Insulin Action
Pan, D. A., Lillioja, S., Kriketos, A. D., Milner, M. R., Baur, L. A., Bogardus, C., Jenkins, A. B., & Storlien, L. H. (1997) · Diabetes · doi:10.2337/diab.46.6.983 · Cited by 1,179 · cited 1×
“The increased deposition of intramyocellular TAG (imTAG) has received special interest, because several studies have demonstrated a positive association between insulin resistance and imTAG storage (1,2).”
BackgroundSkeletal muscle triglyceride levels are inversely related to insulin action
Pan, D. A., Lillioja, S., Kriketos, A. D., Milner, M. R., Baur, L. A., Bogardus, C., Jenkins, A. B., & Storlien, L. H. (1997) · Diabetes · doi:10.2337/diabetes.46.6.983 · Cited by 1,179
Cited by
(n-3) Fatty Acids Alleviate Adipose Tissue Inflammation and Insulin Resistance: Mechanistic Insights
Kalupahana, N. S., Claycombe, K. J., & Moustaid-Moussa, N. (2011) · Advances in Nutrition · doi:10.3945/an.111.000505 · Cited by 305
Kalupahana, N. S., Claycombe, K., Newman, S. J., Stewart, T., Siriwardhana, N., Matthan, N., Lichtenstein, A. H., & Moustaid-Moussa, N. (2010) · The Journal of Nutrition · doi:10.3945/jn.110.125732 · Cited by 301
Regulatory enzymes of mitochondrial β‐oxidation as targets for treatment of the metabolic syndrome
Schreurs, M., Kuipers, F., & Van Der Leij, F. R. (2010) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00642.x · Cited by 296
“Although obesity is associated with increased lipid oxidation (44), accumulation of triglycerides in muscle tissue in type 2 diabetes has been observed (45).”
BackgroundSeifert, E. L., Estey, C., Xuan, J. Y., & Harper, M.-E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.026203 · Cited by 280
Omega-3 Fatty Acids and Skeletal Muscle Health
Jeromson, S., Gallagher, I., Galloway, S., & Hamilton, D. (2015) · Marine Drugs · doi:10.3390/md13116977 · Cited by 203
Metadata
- Authors
- Wensaas, A. J., Rustan, A. C., Just, M., Berge, R. K., Drevon, C. A., & Gaster, M.
- Affiliations
- University of Oslo (NO)
- Odense University Hospital (DK)
- Haukeland University Hospital (NO)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2009-03-01
- Volume
- 58
- Issue
- 3
- Pages
- 527-535
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2646050
- OpenAlex
- W2110135879
- Cited by
- 73
- References
- 51
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 1 · 2023: 2 · 2022: 3 · 2021: 4 · 2020: 5 · 2019: 3 · 2018: 3 · 2017: 4 · 2016: 1 · 2015: 3 · 2014: 2 · 2013: 5 · 2012: 4
- FWCI
- 9.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- type 2 diabetes, skeletal muscle myotubes, fatty acid beta-oxidation, fatty acid oxidation, eicosapentaenoic acid, tetradecylthioacetic acid, palmitic acid, triglyceride accumulation, mitochondrial dysfunction, glucose oxidation, insulin resistance, acyl-CoA, fatty acid uptake, gene expression
- MeSH terms
- Uncoupling Protein 2, Fatty Acid Binding Protein 3, Carbon Dioxide, Carbon Radioisotopes, Carnitine O-Palmitoyltransferase, Diabetes Mellitus, Type 2, Fatty Acids, Glucose, Humans, Insulin, Ion Channels, Lipids, Oxidation-Reduction, Reference Values, Sulfides, Eicosapentaenoic Acid, Muscle Fibers, Skeletal, Oleic Acid, Palmitic Acid, Reverse Transcriptase Polymerase Chain Reaction, Mitochondrial Proteins, Myoblasts, Fatty Acid-Binding Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.